Antibody-drug conjugate T-DM1 treatment for HER2+ breast cancer induces ROR1 and confers resistance through activation of Hippo transcriptional coactivator YAP1
抗体-药物偶联物 T-DM1 治疗 HER2+ 乳腺癌可诱导 ROR1 并通过激活 Hippo 转录辅激活因子 YAP1 产生耐药性
期刊:EBioMedicine
影响因子:9.7
doi:10.1016/j.ebiom.2019.04.061
Syed S Islam, Mohammed Uddin, Abu Shadat M Noman, Hosneara Akter, Nusrat J Dity, Mohammad Basiruzzman, Furkan Uddin, Jahanara Ahsan, Sunera Annoor, Ayodele A Alaiya, Monther Al-Alwan, Herman Yeger, Walid A Farhat
